Assistant Professor, Pediatric Infectious Diseases
Children's Mercy Kansas City
Hina Zaidi, M.D. has been a member of the Pediatric Infectious Diseases faculty at Children's Mercy Hospitals & Clinics, Kansas City, Missouri since 2017.
At Children’s Mercy her time is mostly focused on clinical care for immunocompromised children, while conducting research that is focused on investigating procalcitonin as a biomarker for its reliability in predicting infectious risk in children. In addition, Dr. Zaidi is currently working on a QI project to improve family education regarding infectious disease prevention strategies in post heart transplant patients and serves on the Heart Transplant committee for the hospital. She also serves a role on the hospital sepsis committee, with goals to identify children early at risk for sepsis. She is a sub-investigator for an ongoing GlaxoSmithKline (GSK) Baby Meningitis B vaccine clinical study trial.
Dr. Zaidi obtained her HBSc at McMaster University, Ontario Canada. She completed her medical school training from SABA University School of Medicine, Netherlands Antilles in 2011. She then completed her Pediatric residency in 2014, and Pediatric Infectious Diseases fellowship in 2017, both at Stony Brook Children’s Hospital, Long Island, NY.
Dr. Zaidi is a member of Pediatric Infectious Diseases Society (PIDS), American Society of Transplantation (AST), the Infectious Diseases Society of America (IDSA) and a fellow of the American Academy of Pediatrics (AAP).
She enjoys traveling to explore new places, nature walks and enjoys baking sweet treats.
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.